# Sunrise

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sunrise-3

- Industry: Medical Devices & Equipment
- Headquarters: Namur, Belgium
- Website: www.hellosunrise.com
- Total disclosed funding: $3.7M
- Latest round: Seed (Dec 9, 2021)
- Investors on record: 4

## About

Sunrise SPRL develops innovative solutions for diagnosing sleep apnea, focusing on a proprietary home sleep test technology that allows for non-invasive monitoring and rapid results delivery. Founded in 2015 in Belgium, Sunrise SPRL specializes in sleep apnea diagnosis through advanced home testing technology. Laurent Martinot and Pierre Martinot founded the company. Sunrise offers a compact 8-gram sensor that serves as a non-invasive method for monitoring respiratory effort during sleep. This FDA De Novo approved technology is a pioneering device recommended by the National Institute for Health and Care Excellence (NICE) for home diagnosis of obstructive sleep apnea. The system provides rapid results and integrates a digital platform for healthcare professionals to access reports and data, catering to a clientele of healthcare providers primarily in the United States, with expansion into European and global markets. Sunrise generates revenue through direct sales and partnerships with healthcare providers for its sleep testing devices, which require a prescription. The company also provides digital services that accompany the devices. The recent EBITDA for 2023 stands at EUR -2,025,695.30, driven by the adoption of its proprietary home sleep test technology and related digital solutions. In September 2025, Sunrise SA raised USD 29 million in venture funding led by new investor Eurazeo, with participation from other new investors Amazon, Investsud, Majycc eSante Invest, Noshaq, and Seventure Partners. Returning investors Invest.BW, Invest Mons-Borinage-Centre, Kurma Partners, Namur Invest, Sambrinvest, and Vives also participated in the round. The company plans to utilize the September 2025 funding to expand sleep care access and improve diagnostic technology.

## Funding rounds

- Seed, Dec 9, 2021, $3.7M — Vives, Kurma Partners, Namur Invest, European Innovation Council

## Investors

- Vives (https://capitalatlas.ai/funds/vives) — Seed
- Kurma Partners (https://capitalatlas.ai/funds/kurma-partners) — Seed
- Namur Invest (https://capitalatlas.ai/funds/namur-invest) — Seed
- European Innovation Council (https://capitalatlas.ai/funds/european-innovation-council) — Seed